Dr. Gelmann is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
177 Ft Washingtn Ave
New York, NY 10032Phone+1 212-305-8602- Is this information wrong?
Education & Training
- University of ChicagoResidency, Internal Medicine, 1976 - 1978
- Stanford University School of MedicineClass of 1976
Certifications & Licensure
- CA State Medical License 1979 - Present
- NY State Medical License 2007 - 2026
- AZ State Medical License 2018 - 2024
- DC State Medical License 1988 - 2024
- MD State Medical License 1978 - 2024
- IL State Medical License 1977 - 1987
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2009-2014
- America's Top Doctors Castle Connolly, 2006-2014
- New York Magazine: Top Doctors Castle Connolly, 2010-2013
- Join now to see all
Clinical Trials
- Nitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy Start of enrollment: 2000 May 01
- S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer Start of enrollment: 2013 Mar 08
Publications & Presentations
PubMed
- 2 citationsAndrogen-targeting therapeutics mitigate the adverse effect of GnRH agonist on the risk of neurodegenerative disease in men treated for prostate cancer.Gregory L Branigan, Georgina Torrandell-Haro, Maira Soto, Edward P Gelmann, Francesca Vitali, Kathleen E Rodgers, Roberta Diaz Brinton> ;Cancer Medicine. 2022 Jul 1
- The expanding role of hormones in cancer.Edward P Gelmann> ;Endocrine Oncology. 2021 Jan 1
- 2 citationsCRISPR/Cas9-Mediated Point Mutation in Nkx3.1 Prolongs Protein Half-Life and Reverses Effects Nkx3.1 Allelic Loss.Cai Bowen, Maho Shibata, Hailan Zhang, Sarah K. Bergren, Michael M. Shen, Edward P. Gelmann> ;Cancer Research. 2020 Jan 1
- Join now to see all
Press Mentions
- Targeting the Engine Room of the Cancer CellJune 19th, 2018
- Targeting the Engine Room of the Cancer CellJune 18th, 2018
Grant Support
- Protocol Specific Research ResourceNational Cancer Institute2008–2011
- Crmo- Clinical Research Management OfficeNational Cancer Institute2008–2011
- Genetic Polymorphism In Prostate CancerNational Institute Of Environmental Health Sciences2007
- Cancer And Leukemia Group BNational Cancer Institute2003–2006
- Genetic Polymorphism In Prostate CancerNational Institute Of Environmental Health Sciences1999–2006
- Beta Catenin In Prostate CancerNational Cancer Institute2002–2005
- Prostate, Lung, Colorectal &Ovarian Cancer Screening Tria-261925522National Cancer Institute2003
- Cancer And Acute Leukemia Group B (CALGB) Inst GrantNational Cancer Institute2001–2002
- Beta Catenin In Prostate CancerNational Cancer Institute2000–2001
- Apoptosis In Prostate CancerNational Cancer Institute1999–2001
- Prostate, Lung, Colorectal &Ovarian CancerDivision Of Cancer Prevention And Control1994–2000
- Nkx31 In Prostate CancerNational Cancer Institute1998–1999
- Markers For Malignant Progression In Prostate CancerNational Cancer Institute1992–1996
- Specialized PGM Of Research Excellence/Prostate CancerNational Cancer Institute1992–1994
- Molecular Mechanisms For Prostate Cancer Cell GrowthNational Cancer Institute1990–1992
Professional Memberships
- Member
Hospital Affiliations
- Tucson VA Medical CenterTucson, Arizona
- Banner - University Medical Center TucsonTucson, Arizona
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: